⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
AMPK Activators
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-14 — Identification of mitophagy inducers for Alzheimer’s disease via high-throughput endogenous ATP5B tagging system.: cross-connection with mitophagy-inducers: [animal-model] The flupentixol study links mitophagy induction to mitochondrial AMPK recruitment and activation in preclinical experiments, without establishing that other AMPK activators reproduce its effects. (novelty: 3)
- 2026-09-29 — Direct Pharmacological Activation of AMPK Extends Lifespan in Yeast, Worms and Flies: Direct pharmacological AMPK activation extended lifespan across three invertebrate models (yeast, C. elegans, Drosophila) — confirmatory cross-species preclinical signal on a nutrient-sensing target already linked to metformin and caloric restriction; no mammalian lifespan or human outcome data. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Direct Pharmacological Activation of AMPK Modestly Extends Life in Short-Lived Species
07-oct-2026
novelty 2
per-area 2
introduces
Direct Pharmacological Activation of AMPK Extends Lifespan in Yeast, Worms and Flies
29-sep-2026
novelty 3
per-area 3
strengthens